Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 5.90x is in line with its estimated 1-year average of 5.93x, around the middle of its estimated 1-year range (5.07x–6.88x).
As of 2026-10-06T22:35:26.704Z. 0.50% below its estimated 12-month average of 5.93x.
Calculation as of: 2026-10-06T22:35:26.704Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 23f55305a71a3950b031d13a123c7a4da2ce3ae96893c1a2d36d58e557527924
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
5.90x
EV/EBITDA RATIO AVG TTM
5.93x
EV/EBITDA RATIO AVG 3Y
5.93x
EV/EBITDA RATIO AVG 5Y
5.93x
EV/EBITDA RATIO AVG 10Y
5.93x
EV/EBITDA RATIO AVG 15Y
5.93x
EV/EBITDA RATIO AVG 20Y
5.95x
CURRENT VS TTM AVG
-0.50%
CURRENT VS 3Y AVG
-0.50%
CURRENT VS 5Y AVG
-0.50%
CURRENT VS 10Y AVG
-0.50%
CURRENT VS 15Y AVG
-0.50%
CURRENT VS 20Y AVG
-0.84%
SECTOR MEDIAN · HEALTHCARE
15.76x
median of 216 covered companies
CURRENT VS SECTOR MEDIAN
-62.56%
vs the sector median at left
Arbutus Biopharma Corp
Market Cap
$884.97M
EV/EBITDA Ratio
5.90x
TTM Avg
5.93x
3Y Avg
5.93x
5Y Avg
5.93x
Market Cap
$887.99M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$870.81M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$857.16M
EV/EBITDA Ratio
N/A
TTM Avg
19.31x
3Y Avg
12.44x
5Y Avg
8.61x
Market Cap
$914.73M
EV/EBITDA Ratio
12.55x
TTM Avg
10.56x
3Y Avg
12.81x
5Y Avg
13.69x
Market Cap
$853.13M
EV/EBITDA Ratio
9.28x
TTM Avg
6.28x
3Y Avg
11.56x
5Y Avg
11.56x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $884.97M | 5.90x | 5.93x | 5.93x | 5.93x |
| Bioventus Inc. (BVS)vs › | $887.50M | 10.48x | 9.34x | 18.56x | 25.76x |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | N/A | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | N/A | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | N/A | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | N/A | 19.31x | 12.44x | 8.61x |
| Alumis Inc. (ALMS)vs › | $855.38M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 12.55x | 10.56x | 12.81x | 13.69x |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 9.28x | 6.28x | 11.56x | 11.56x |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | N/A | N/A | N/A | N/A |
At 5.9, EV/EBITDA is near its estimated 19-year median — higher than 50% of readings in its estimated 19-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 19-year low
1.9
median
5.9
estimated 19-year high
10.1
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 6.16x |
| 2026-10-02 | 5.86x |
| 2026-10-01 | 6.01x |
| 2026-09-30 | 6.30x |
| 2026-09-29 | 6.18x |
| 2026-09-28 | 6.41x |
| 2026-09-25 | 6.40x |
| 2026-09-24 | 6.44x |
| 2026-09-23 | 6.40x |
| 2026-09-22 | 6.61x |
| 2026-09-21 | 6.60x |
| 2026-09-18 | 6.61x |
| 2026-09-17 | 6.69x |
| 2026-09-16 | 6.67x |
| 2026-09-15 | 6.68x |
| 2026-09-14 | 6.77x |
| 2026-09-11 | 6.76x |
| 2026-09-10 | 6.76x |
| 2026-09-09 | 6.83x |
| 2026-09-08 | 6.84x |
| 2026-09-04 | 6.80x |
| 2026-09-03 | 6.76x |
| 2026-09-02 | 6.73x |
| 2026-09-01 | 6.72x |
| 2026-08-31 | 6.71x |
| 2026-08-28 | 6.69x |
| 2026-08-27 | 6.83x |
| 2026-08-26 | 6.85x |
| 2026-08-25 | 6.87x |
| 2026-08-24 | 6.87x |
| 2026-08-21 | 6.88x |
| 2026-08-20 | 6.29x |
| 2026-08-19 | 6.57x |
| 2026-08-18 | 6.38x |
| 2026-08-17 | 6.21x |
| 2026-08-14 | 6.16x |
| 2026-08-13 | 6.04x |
| 2026-08-12 | 5.66x |
| 2026-08-11 | 5.76x |
| 2026-08-10 | 5.66x |
| 2026-08-07 | 5.71x |
| 2026-08-06 | 5.60x |
| 2026-08-05 | 5.70x |
| 2026-08-04 | 5.45x |
| 2026-08-03 | 5.37x |
| 2026-07-31 | 5.35x |
| 2026-07-30 | 5.44x |
| 2026-07-29 | 5.29x |
| 2026-07-28 | 5.44x |
| 2026-07-27 | 5.44x |
| 2026-07-24 | 5.40x |
| 2026-07-23 | 5.51x |
| 2026-07-22 | 5.34x |
| 2026-07-21 | 5.58x |
| 2026-07-20 | 5.44x |
| 2026-07-17 | 5.63x |
| 2026-07-16 | 5.85x |
| 2026-07-15 | 5.63x |
| 2026-07-14 | 5.69x |
| 2026-07-13 | 5.76x |
| 2026-07-10 | 5.93x |
| 2026-07-09 | 6.36x |
| 2026-07-08 | 6.46x |
| 2026-07-07 | 6.41x |
| 2026-07-06 | 6.14x |
| 2026-07-02 | 6.02x |
| 2026-07-01 | 5.84x |
| 2026-06-30 | 5.93x |
| 2026-06-29 | 5.78x |
| 2026-06-26 | 5.65x |
| 2026-06-25 | 5.44x |
| 2026-06-24 | 5.50x |
| 2026-06-23 | 5.49x |
| 2026-06-22 | 5.58x |
| 2026-06-18 | 5.61x |
| 2026-06-17 | 5.46x |
| 2026-06-16 | 5.41x |
| 2026-06-15 | 5.32x |
| 2026-06-12 | 5.25x |
| 2026-06-11 | 5.29x |
| 2026-06-10 | 5.07x |
| 2026-06-09 | 5.23x |
| 2026-06-08 | 5.22x |
| 2026-06-05 | 5.23x |
| 2026-06-04 | 5.36x |
| 2026-06-03 | 5.36x |
| 2026-06-02 | 5.25x |
| 2026-06-01 | 5.52x |
| 2026-05-29 | 5.63x |
| 2026-05-28 | 5.68x |
| 2026-05-27 | 5.73x |
| 2026-05-26 | 5.73x |
| 2026-05-22 | 5.36x |
| 2026-05-21 | 5.47x |
| 2026-05-20 | 5.39x |
| 2026-05-19 | 5.17x |
| 2026-05-18 | 5.13x |
| 2026-05-15 | 5.22x |
| 2026-05-14 | 5.36x |
| 2008-06-30 | 2.98x |
| 2008-06-27 | 3.91x |
| 2008-06-26 | 3.13x |
| 2008-06-25 | 4.06x |
| 2008-06-24 | 1.89x |
| 2008-06-23 | 3.13x |
| 2008-06-20 | 3.13x |
| 2008-06-19 | 3.75x |
| 2008-06-18 | 3.60x |
| 2008-06-17 | 3.29x |
| 2008-06-16 | 3.60x |
| 2008-06-13 | 2.98x |
| 2008-06-12 | 4.68x |
| 2008-06-11 | 3.91x |
| 2008-06-10 | 6.23x |
| 2008-06-09 | 7.78x |
| 2008-06-06 | 7.93x |
| 2008-06-05 | 9.64x |
| 2008-06-04 | 9.64x |
| 2008-06-03 | 9.79x |
| 2008-06-02 | 9.48x |
| 2008-05-30 | 9.64x |
| 2008-05-29 | 9.64x |
| 2008-05-28 | 10.10x |
| 2008-05-27 | 10.10x |
| 2008-05-23 | 9.02x |
| 2008-05-22 | 9.02x |
| 2008-05-21 | 8.40x |
| 2008-05-20 | 8.55x |
| 2008-05-19 | 7.93x |
| 2008-05-16 | 7.93x |
| 2008-05-15 | 7.31x |
| 2008-05-14 | 6.69x |
| 2008-05-13 | 6.38x |
| 2008-05-12 | 6.38x |
| 2008-05-09 | 6.38x |
| 2008-05-08 | 6.54x |
| 2008-05-07 | 7.16x |
| 2008-05-06 | 6.23x |
| 2008-05-05 | 6.07x |
| 2008-05-02 | 6.07x |
| 2008-05-01 | 5.77x |
| 2008-04-30 | 5.15x |
| 2008-04-29 | 4.99x |
| 2008-04-28 | 6.07x |
| 2008-04-25 | 5.30x |
| 2008-04-24 | 4.53x |
| 2008-04-23 | 4.53x |
| 2008-04-22 | 5.92x |
| 2008-04-21 | 5.92x |
| 2008-04-18 | 5.92x |
| 2008-04-17 | 4.06x |
| 2008-04-16 | 5.61x |
| 2008-04-15 | 5.61x |
| 2008-04-14 | 5.61x |
| 2008-04-11 | 5.61x |
| 2008-04-10 | 5.92x |
| 2008-04-09 | 7.62x |
| 2008-04-08 | 7.62x |
| 2008-04-07 | 6.23x |
| 2008-04-04 | 6.38x |
| 2008-04-03 | 6.69x |
| 2008-04-02 | 7.16x |
| 2008-04-01 | 9.02x |
